Acetazolamide: Clinical Trials

157 trials of Acetazolamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

82 completed, 22 recruiting, 22 unknown, 12 terminated. 55 Phase 4, 45 Phase 2, 23 Not applicable, 20 Phase 1, 20 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 455Completed 38, Unknown 7, Recruiting 6, Terminated 2, Active not recruiting 1, Not yet recruiting 1
Phase 245Completed 20, Recruiting 11, Withdrawn 5, Terminated 4, Unknown 3, Active not recruiting 2
Not applicable23Completed 11, Unknown 4, Recruiting 3, Withdrawn 3, Active not recruiting 1, Not yet recruiting 1
Phase 120Completed 10, Recruiting 5, Active not recruiting 3, Terminated 2
Phase 320Terminated 7, Completed 6, Unknown 5, Not yet recruiting 1, Recruiting 1
Early Phase 15Completed 2, Active not recruiting 1, Unknown 1, Withdrawn 1

Follow Acetazolamide: new trials by email Literature Review of Acetazolamide trials Research Report on Acetazolamide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.
Acetazolamide, Furosemide - Heart Failure
Phase 3Not yet recruitingUniversity Hospital, Montpellier3662026-10-012026-08-17
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamide, IHL-42X: 5 mg dronabinol + 125 mg acetazolamide, IHL-42X: 7.5 mg dronabinol + 125 mg acetazolamide - Obstructive Sleep Apnea (OSA)
Phase 2RecruitingIncannex Healthcare Ltd1202026-07-212026-10-13
TACTIC-HF: Sequential Diuretic Strategies in Ambulatory Worsening Heart Failure
Intravenous furosemide bolus injections, ACETAZOLAMIDE oral capsule, Hydrochlorothiazide (HCT) - Acute Heart Failure (AHF)
Phase 4Not yet recruitingLucrecia Maria Burgos602026-06-152026-05-18
Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management
lumbo-peritoneal shunt, Conservative Management: Centered on lifestyle modifications for weight reduction, alongside targeted medical therapies including carbonic anhydrase inhibitors (e.g., acetazolamide) and/or topiramate. - Idiopathic Intracranial Hypertension
Not applicableActive not recruitingSohag University302026-06-012026-07-21
Add-on Diuretics in Acute Decompensated Heart Failure
empagliflozin, Acetazolamide, metolazone - Acute Decompensated Heart Failure
Phase 2RecruitingTanta University662026-02-012026-02-04
Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide
Acetazolamide, Stent (Tentos 4F or Precise ProRX) - Idiopathic Intracranial Hypertension (IIH)
Not applicableRecruitingUniversity Hospital, Montpellier1142026-01-052026-03-06
Preoperative Acetazolamide
Acetazolamide 500 MG Extended Release Oral Capsule, Placebo - Post Operative Pain, Laparoscopic Hysterectomy
Phase 4RecruitingPrisma Health-Upstate1002025-10-302026-10-06
Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure
Acetazolamide, Metolazone - Acute Decompensated Heart Failure, Heart Failure, Diastolic
Not applicableRecruitingUniversity of Health Sciences Lahore3202025-10-112025-10-03
Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder
Acetazolamide, Placebo - Central Sleep Apnea Comorbid With Opioid Use
Phase 2RecruitingSanjay R Patel402025-09-302026-06-25
Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase
Best medical care, Intervention (stenting) - Idiopathic Intracranial Hypertension (IIH)
Not applicableRecruitingUniversity Hospital, Montpellier1142025-09-192025-10-03
The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude
ACETAZOLAMIDE oral capsule, Placebo Arm - Hypoxemia, Acute Mountain Sickness (AMS)
Early Phase 1Active not recruitingUniversity of California, Riverside192025-09-172026-04-08
Acetazolamide to Reduce Spinal Fluid Leaks After Spine Surgery.
Acetazolamide, Standard Care (in control arm) - Cerebrospinal Fluid Leak, Dural Tear
Phase 4CompletedAin Shams University262025-04-062026-10-15
Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
Sivopixant, Placebo, Acetazolamide - Sleep Apnea
Phase 2Active not recruitingShionogi602025-04-022026-05-06
A Noninvasive Arterial Input Estimation Method for O-15 PET and Integrated PET/MR Scanning
[O-15]Water, Acetazolamide - Validation of a New Noninvasive Method to Obtain the Arterial Input Function (AIF) Directly by PET Imaging
Early Phase 1WithdrawnUniversity of Alabama at Birmingham2025-02-012024-03-01
Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload
Acetazolamide, Metolazone 2.5 MG, Double-placebo - Acute Heart Failure
Phase 4RecruitingJohannes Grand9392024-09-052026-08-14
Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients
Acetazolamide, Dapagliflozin 10mg - Acute Decompensated Heart Failure
Phase 3UnknownHelwan University602024-08-242024-08-05
Assessing the Clinical Outcomes of Dapagliflozin Versus Acetazolamide in Patients With Acute Heart Failure
Dapagliflozin 10mg, Acetazolamide 500mg - Acute Heart Failure
Phase 2 / Phase 3RecruitingMansoura University1002024-08-152025-01-20
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
Acetazolamide, Placebo - Type 1 Diabetes
Phase 2RecruitingUniversity of California, San Diego252024-08-142025-06-17
HighCycle Study: Acetazolamide, High Altitude and Plasma Volume
Acetazolamide, Placebo - High Altitude Effects, High Altitude Hypoxia
Phase 4RecruitingCentre d'Expertise sur l'Altitude EXALT2702024-07-152025-08-12
HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men
Acetazolamide, Placebo - Sleep-Disordered Breathing
Phase 4CompletedUniversity of Zurich3032024-07-152026-06-05

Showing 20 of 157. Sign in to see all of them.

Conditions studied

Altitude Sickness (29)  ·  Sleep Apnea, Obstructive (17)  ·  Hypoxia (12)  ·  Sleep Apnea Syndromes (12)  ·  Pulmonary Disease, Chronic Obstructive (11)  ·  Heart Failure (9)  ·  Hypertension, Pulmonary (6)  ·  Pseudotumor Cerebri (6)  ·  Emphysema (5)  ·  Cerebrospinal Fluid Leak (4)  ·  Edema (4)  ·  Sleep Apnea, Central (4)  ·  Alkalosis (3)  ·  Apnea (3)  ·  Glaucoma (3)

Sponsors

University of Zurich (26)  ·  University of California, San Diego (6)  ·  VA Office of Research and Development (4)  ·  Brigham and Women's Hospital (3)  ·  Incannex Healthcare Ltd (3)  ·  Stanford University (3)  ·  Tehran University of Medical Sciences (3)  ·  University Hospital, Antwerp (3)  ·  University Hospital, Montpellier (3)  ·  University of Miami (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Ain Shams University (2)  ·  Centre d'Expertise sur l'Altitude EXALT (2)  ·  Danish Headache Center (2)  ·  Mayo Clinic (2)

Countries

United States (53)  ·  Kyrgyzstan (22)  ·  Egypt (7)  ·  Belgium (6)  ·  Canada (6)  ·  France (6)  ·  Iran (6)  ·  Switzerland (6)  ·  Israel (4)  ·  Denmark (3)  ·  Netherlands (3)  ·  Peru (3)  ·  Brazil (2)  ·  Chile (2)  ·  India (2)

Top investigators

Konrad E Bloch, MD (16)  ·  Talant M Sooronbaev, MD (14)  ·  Michael Furian, MSc (8)  ·  Silvia Ulrich, MD (8)  ·  Michael Furian, Prof. Dr. (3)  ·  Talant Sooronbaev, Prof. Dr. (3)  ·  Christopher Schmickl, MD, PhD (2)  ·  Glen E Foster, Ph.D. (2)  ·  Michael Wall, MD (2)  ·  Olivier Vanderveken, MD, PhD (2)  ·  Susmita Chowdhuri, MD MS (2)  ·  Talant M Sooronbaev (2)  ·  Talant M Sooronbaev,, MD (2)  ·  Vishnumurthy S Hedna, MD (2)

Results publications

PMID 38296630, PMID 10662747, PMID 11772581, PMID 11904109, PMID 11927799, PMID 12119802, PMID 12832331, PMID 14581110, PMID 15066944, PMID 15710782, PMID 15738343, PMID 15911704, PMID 15983467, PMID 16391986, PMID 17515447, PMID 17515448, PMID 18071739, PMID 18388356, PMID 18719057, PMID 19687359, PMID 20837887, PMID 21965050, PMID 22278334, PMID 22311903, PMID 22943271, PMID 22994519, PMID 23098412, PMID 23292683, PMID 23578004, PMID 24002370, PMID 24227635, PMID 24366914, PMID 24495468, PMID 24606242, PMID 24721800, PMID 24756302, PMID 24756514, PMID 24781936, PMID 24991933, PMID 25370510, PMID 25370513, PMID 26024112, PMID 26335066, PMID 26618282, PMID 26778344, PMID 26824595, PMID 26836730, PMID 26934136, PMID 27121942, PMID 27271310

NIH funding

2017 (9), 2025 (1), I01CX001944 (1), K23HL151880 (1), K23HL161336 (1), R01DA059465 (1), R01EY014957 (1), R01HL136484 (1), R01HL160993 (1), U10EY017281 (1), U10EY017387 (1), U10EY025990 (1), U54NS059065 (1), UL1TR000445 (1)